We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 26 results
  1. Prophylaxe und Therapie Tumortherapie-induzierter Nausea und Emesis

    Nausea and vomiting are still among the most feared side effects of antineoplastic therapy. Optimal antiemetic prophylaxis is therefore essential. In...

    F. Jahn, T. Behlendorf, K. Jordan in Die Onkologie
    Article 16 May 2024
  2. Chemotherapieinduzierte Nausea und Emesis

    Chemotherapy-induced nausea and the subsequent vomiting (CINV) are adverse effects of cancer treatment associated with considerable burden for the...

    Meinolf Karthaus in HNO
    Article 02 June 2023
  3. Chemotherapieinduzierte Nausea und Emesis

    Chemotherapy-induced nausea and the subsequent vomiting (CINV) are adverse effects of cancer treatment associated with considerable burden for the...

    Meinolf Karthaus in best practice onkologie
    Article 14 April 2023
  4. Kombination Radio(chemo)therapie beim Lungenkarzinom – Nebenwirkungsmanagement

    Simultaneous chemoradiotherapy (CRT) is the standard treatment for locally advanced non-small cell lung cancer (NSCLC) in stage III and for limited...

    Kim Melanie Kraus, Ruth Eichner, Stephanie Elisabeth Combs in best practice onkologie
    Article 10 October 2023
  5. Prophylaxe von Übelkeit und Erbrechen nach medikamentöser Tumortherapie

    The frequency and severity of nausea and/or vomiting in patients receiving anticancer drugs are influenced by numerous factors, e.g., by the specific...

    Hartmut Link in Die Urologie
    Article 10 June 2022
  6. Chemotherapieinduzierte Nausea und Emesis

    The chemotherapy-induced nausea and vomiting (CINV) is one of the most frequent side effects in cytostatic therapy and a profound challenge during...

    E. Storz, J. E. Gschwend, M. Retz in Der Urologe
    Article 27 March 2018
  7. Nebenwirkungen der Chemotherapie

    Urologic tumors are frequently treated by multimodal therapeutic strategies with the consequence of an increasing number of adverse events. The most...

    K. Hauner, P. Maisch, M. Retz in Der Urologe
    Article 01 March 2017
  8. Kleinzelliges Lungenkarzinom

    Background

    Prognostic improvements for patients with small cell lung cancer (SCLC) have been achieved within the last decade especially due to the use...

    M. B. Steins, C. Henkenberens, ... M. Thomas in Der Onkologe
    Article 29 June 2016
  9. Leitliniengerechte Antiemese in der gynäko-onkologischen Praxis

    Jörg Schilling, Hans-Joachim Hindenburg in Im Focus Onkologie
    Article 26 October 2015
  10. Perioperative Schmerztherapie in der Orthopädie

    A sufficient pain management forms the foundation for a successful operative treatment of orthopedic patients. Clinical guideline standards must be...

    T. Fikentscher, J. Grifka, A. Benditz in Der Orthopäde
    Article 29 August 2015
  11. Übelkeit und Fatigue: Schon morgens immer müde

    Axel Doll, Britta Wels in Heilberufe
    Article 01 July 2013
  12. Supportive Maßnahmen im Fokus

    Bettina Reich in Im Focus Onkologie
    Article 30 March 2012
  13. Entwicklungen der modernen Onkologie

    Patients with solid tumors and hematological neoplasia can be a special challenge for anesthetists with their multilayered core competences...

    B. Alt-Ep**, S. Alt-Ep**, ... F. Nauck in Der Anaesthesist
    Article 20 May 2009
  14. Supportivmaßnahmen in der gynäkologischen Onkologie

    Hematological toxicities due to currently available chemotherapies or regimens are manageable in most cases, and are often considered by the patients...

    P. Harter, A. du Bois in Der Gynäkologe
    Article 19 July 2007
Did you find what you were looking for? Share feedback.